Assessing the impact of a Vi-polysaccharide conjugate vaccine in preventing typhoid infection among Bangladeshi children: A protocol for a phase IIIb trial
Typhoid fever illnesses are responsible for more than 100 000 deaths worldwide each year. In Bangladesh, typhoid fever is endemic, with incidence rates between 292-395 per 100 000 people annually. While considerable effort has been made to improve access to clean water and sanitation services in the...
Main Authors: | Theiss-Nyland, K, Qadri, F, Colin-Jones, R, Zaman, K, Khanam, F, Liu, X, Voysey, M, Khan, A, Hasan, N, Ashher, F, Farooq, Y, Pollard, A, Clemens, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2019
|
Similar Items
-
Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysis
by: Khanam, F, et al.
Published: (2023) -
Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV)
by: Voysey, M, et al.
Published: (2018) -
Assessing the impact of a vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepalese children: a protocol for a phase III, randomized control trial
by: Theiss-Nyland, K, et al.
Published: (2019) -
Prevention of enteric fever in travellers with typhoid conjugate vaccines
by: Britto, C, et al.
Published: (2018) -
Immune responses in children after vaccination with a typhoid Vi-tetanus toxoid conjugate vaccine in Bangladesh
by: Khanam, F, et al.
Published: (2023)